JPMorgan Chase & Co. Has $5.29 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY

JPMorgan Chase & Co. cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 416,856 shares of the medical instruments supplier’s stock after selling 98,640 shares during the period. JPMorgan Chase & Co. owned approximately 0.21% of DENTSPLY SIRONA worth $5,290,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Trust & Banking Corp increased its holdings in DENTSPLY SIRONA by 1,836.7% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock worth $1,344,000 after purchasing an additional 100,468 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in shares of DENTSPLY SIRONA by 38.4% in the third quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock valued at $10,215,000 after purchasing an additional 223,339 shares in the last quarter. CWM LLC boosted its position in shares of DENTSPLY SIRONA by 84.3% during the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after buying an additional 192,373 shares during the last quarter. Invenomic Capital Management LP boosted its position in shares of DENTSPLY SIRONA by 48.7% during the third quarter. Invenomic Capital Management LP now owns 4,351,199 shares of the medical instruments supplier’s stock valued at $55,217,000 after buying an additional 1,425,637 shares during the last quarter. Finally, Advisors Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 42.8% during the third quarter. Advisors Asset Management Inc. now owns 348,989 shares of the medical instruments supplier’s stock worth $4,429,000 after buying an additional 104,588 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $11.66 on Thursday. The business’s fifty day simple moving average is $12.52 and its 200 day simple moving average is $12.16. The company has a current ratio of 1.51, a quick ratio of 1.03 and a debt-to-equity ratio of 1.50. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $17.18. The firm has a market capitalization of $2.33 billion, a P/E ratio of -3.89, a price-to-earnings-growth ratio of 1.36 and a beta of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The business had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

Analyst Ratings Changes

XRAY has been the topic of several recent analyst reports. Bank of America upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and raised their price objective for the company from $13.00 to $17.00 in a research note on Thursday, February 19th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Barclays initiated coverage on shares of DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, January 21st. Finally, Mizuho upped their price objective on shares of DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Monday, March 2nd. Three equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $14.42.

Insider Activity

In related news, Director James D. Forbes acquired 5,000 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was acquired at an average price of $12.48 per share, for a total transaction of $62,400.00. Following the completion of the acquisition, the director owned 10,000 shares of the company’s stock, valued at approximately $124,800. This represents a 100.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gregory T. Lucier acquired 27,555 shares of the stock in a transaction on Monday, March 2nd. The stock was bought at an average cost of $14.24 per share, for a total transaction of $392,383.20. Following the transaction, the director owned 27,555 shares of the company’s stock, valued at approximately $392,383.20. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 70,000 shares of company stock valued at $956,437. 0.50% of the stock is owned by company insiders.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.